Pfiz­er spin­out Spring­Works will ship its first drug to the FDA be­fore year’s end with PhI­II win

Spring­Works Ther­a­peu­tics thinks it has ce­ment­ed the back­bone for its first “pipeline-in-a-prod­uct” on­col­o­gy treat­ment and will send it to the FDA be­fore the clock strikes …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER